1. Academic Validation
  2. Blocking protease-activated receptor 4 alleviates liver injury induced by brain death

Blocking protease-activated receptor 4 alleviates liver injury induced by brain death

  • Biochem Biophys Res Commun. 2022 Mar 5;595:47-53. doi: 10.1016/j.bbrc.2022.01.074.
Hongbo Fang 1 Zibo Yuan 1 Yaohua Zhu 1 Hongwei Tang 2 Chun Pang 1 Jie Li 1 Jihua Shi 2 Wenzhi Guo 3 Shuijun Zhang 4
Affiliations

Affiliations

  • 1 Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China.
  • 2 Henan Key Laboratory for Digestive Organ Transplantation, Zhengzhou City, Henan Province, China; Zhengzhou Key Laboratory for Hepatobiliary & Pancreatic Diseases and Organ Transplantation, Zhengzhou City, Henan Province, China.
  • 3 Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China; Henan Key Laboratory for Digestive Organ Transplantation, Zhengzhou City, Henan Province, China; Zhengzhou Key Laboratory for Hepatobiliary & Pancreatic Diseases and Organ Transplantation, Zhengzhou City, Henan Province, China.
  • 4 Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China; Henan Key Laboratory for Digestive Organ Transplantation, Zhengzhou City, Henan Province, China; Zhengzhou Key Laboratory for Hepatobiliary & Pancreatic Diseases and Organ Transplantation, Zhengzhou City, Henan Province, China. Electronic address: [email protected].
Abstract

Brain death (BD) induces a systemic inflammatory response that influences donor liver quality. Protease-activated Receptor 4 (PAR4) is a Thrombin receptor that mediates platelet activation and is involved in inflammatory and apoptotic processes. Therefore, we investigated the role of PAR4 blockade in liver injury induced by BD and its associated mechanisms. In this study, we constructed a BD rat model and treated rats with TcY-NH2, a selective PAR4 Antagonist, to block PAR4 signaling at the onset of BD induction. Our results revealed that PAR4 protein expression increased in the livers of rats with BD. PAR4 blockade alleviated liver injury induced by BD, as indicated by lower serum ALT/AST levels and an improvement in histomorphology. Blood platelet activation and hepatic platelet accumulation in BD rats were reduced by PAR4 blockade. Additionally, PAR4 blockade attenuated the inflammatory response and Apoptosis in the livers of BD rats. Moreover, the activation of NF-κB and MAPK pathways induced by BD was inhibited by PAR4 blockade. Thus, our results suggest that PAR4 contributes to liver injury induced by BD by regulating inflammation and Apoptosis through the NF-κB and MAPK pathways. Thus, PAR4 blockade may provide a feasible approach to improve the quality of organs from BD donors.

Keywords

Apoptosis; Brain death; Inflammation; Liver injury; Protease-activated receptor 4.

Figures
Products